Modifying Duties Addressing The Synthetic Opioid Supply Chain In The People’s Republic Of China

The order reduces trade penalties previously imposed to pressure China on synthetic opioid exports, reflecting progress in diplomatic negotiations to curb fentanyl flows to the U.S. This signals a shift in U.S.-China relations on narcotics enforcement and supply chain accountability.

What the order does ​

• Cuts the additional tariff on specified Chinese imports from 20% to 10% effective Nov. 10, 2025.
• Updates the Harmonized Tariff Schedule to reflect the new duty rate and implementation date.
• Directs Homeland Security and related agencies to monitor China’s commitments on fentanyl controls.
• Authorizes agency heads to take necessary steps to enforce and adjust measures per compliance.

Who it affects ​

• U.S. importers of covered Chinese goods.
• Chinese chemical and pharmaceutical exporters.
• U.S. enforcement agencies overseeing import compliance.

Context ​

The tariff reduction responds to China’s formal commitment to stricter controls over chemicals linked to synthetic opioids and ongoing U.S.-China negotiations on narcotics suppression.